Tech Company M&A Transactions
NovaCardia Acquisition
NovaCardia was bought by Merck. The transaction occurred on 7/25/2007. Merck said the transaction price was $350 million.
Transaction Overview
Company Name
Acquired By
Announced On
7/25/2007
Transaction Type
M&A
Amount
$350,000,000
M&A Terms
The acquisition will be paid for with all stock.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12651 High Bluff Drive 200
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Not Recorded
Overview
NovaCardia is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Randall Woods
Browse more venture capital transactions:
Prev: 7/25/2007: Cyntellect venture capital transaction
Next: 7/25/2007: Navotek Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs